Publications by authors named "Claudia P Oliveira"

Claim this Profile
U
Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Rodrigo Oliveira Moreira, Claudia P Oliveira

Ann Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study.
Isabel Veloso Alves Pereira, Ana Beatriz Souza de Oliveira, Patricia Momoyo Yoshimura Zitelli, Lais Arrivabene Barbieri, Ana Carolina Cardoso, Juliana Souza de Oliveira, Claudia P Oliveira

Clinics (Sao Paulo)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.
Jeffrey V Lazarus, Leire Agirre-Garrido, Luis Antonio Díaz, Pojsakorn Danpanichkul, Sokoine L Kivuyo, Claudia P Oliveira

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles and microRNAs in metabolic dysfunction-associated steatotic liver disease: from steatosis to hepatocellular carcinoma.
Melina Belén Keingeski, Larisse Longo, Anelise da Silva Pinto, Bruno de Souza Basso, Thalia Michele Vier Schmitz, Claudia P Oliveira

EXCLI J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
Zobair M Younossi, Leyla de Avila, Salvatore Petta, Hannes Hagström, Seung Up Kim, Claudia P Oliveira

Hepatology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Zobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, Vincent Wai-Sun Wong, Yusuf Yilmaz, Claudia Pinto Oliveira

Gastroenterology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.
Luis Antonio Díaz, William Alazawi, Saaket Agrawal, Juan Pablo Arab, Marco Arrese, Claudia P Oliveira

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PORTRESS - the PORTuguese Reuma.pt registry for Sjögren'S disease.
Matilde Bandeira, Manuel Silvério-António, Roberto Pereira da Costa, Ana Rita Lopes, Filipe Cunha Santos, Cláudia Pinto Oliveira, Margarida Oliveira

ARP Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.
Zobair M Younossi, Leyla de Avila, Salvatore Petta, Hannes Hagström, Seung Up Kim, Claudia P Oliveira

Hepatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Latin American consensus on the treatment and prophylaxis of hepatic encephalopathy.
Fátima Higuera-de-la-Tijera, Mario Reis Alvares-da-Silva, Graciela Elia Castro-Narro, Josué Barahona-Garrido, Enrique Carrera-Estupiñán, Claudia P Oliveira

Ann Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, Marco Arrese, Francisco Idalsoaga, Claudia P Oliveira

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: UPDATE.
Maria Gabriela Fernandes Dezan, Claudia Pinto Oliveira, Helma Pinchemel Cotrim

Arq Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.
Zobair M Younossi, James M Paik, Jeffrey V Lazarus, Patrizia Burra, Yuichiro Eguchi, Claudia Pinto Oliveira

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD.
Sofia Rocha, Claudia P Oliveira, José Tadeu Stefano, Roberta P Yokogawa, Michele Gomes-Gouvea

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease.
Monica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, Juan Pablo Arab, Marco Arrese, Claudia P Oliveira

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD).
Santiago Iturbe-Rey, Claudia Maccali, Marco Arrese, Patricia Aspichueta, Claudia P Oliveira

Atherosclerosis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes.
Leonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, Yanina Carlino, Estefanía Liza Baca, Claudia P Oliveira

Lancet Reg Health Am· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification.
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai-Sun Wong, Claudia P Oliveira

Ultrasound Med Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography.
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai-Sun Wong, Claudia P Oliveira

Ultrasound Med Biol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASSOCIATION BETWEEN ANXIETY AND DEPRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD).
Eloyse Cristina Botacin, Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Mary Ellen Dias Barbosa, Mario Guimarães Pessoa, Cláudia P Oliveira

Arq Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High red meat consumption among PNPLA3 polymorphism carriers is associated with NAFLD in a multi-center cross-sectional study.
Mario Reis Alvares-da-Silva, Dana Ivancovsky-Wajcman, Claudia P Oliveira, Soheyla Rabie, Larisse Longo

Eur J Clin Nutr· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?
Taisa Grotta Ragazzo, Patricia Momoyo Yoshimura Zitelli, Daniel F Mazo, Claudia P Oliveira, Flait José Carrilho

Clinics (Sao Paulo)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
Manuel Romero-Gómez, Juan Pablo Arab, Claudia P Oliveira, María Hernández, Marco Arrese

Semin Liver Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease.
Matheus Truccolo Michalczuk, Larisse Longo, Melina Belén Keingeski, Bruno de Souza Basso, Gabriel Tayguara Silveira Guerreiro, Cláudia P Oliveira

World J Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation in Latin America: reality and challenges.
David Aguirre-Villarreal, Maximiliano Servin-Rojas, Aczel Sánchez-Cedillo, Mariana Chávez-Villa, Roberto Hernandez-Alejandro, Claudia P Oliveira

Lancet Reg Health Am· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis